Board of Directors
Read more:
Board of Directors
Gisela Sitbon
Born 1958
Board member since 2012, Chairman since 2014
Chairman of the board, chairman of the remuneration committee
EDUCATION AND TRAINING:
PhD in Medical Sciences from the Karolinska Institute in Solna
MAIN EXPERIENCE:
Gisela Sitbon has over 25 years of experience from the life science industry, of which more than ten years in senior positions (including CEO) at Professional Genetics Laboratory AB and five years as section manager at Karo Bio AB.
OTHER APPOINTMENTS:
Active as business coach within the life science sector. Chairman of the board of Gradientech AB, Emplicure AB, Amplicon AB and Emplipharm AB. Board member of Uppsala Universitet Invest AB, Annexin Pharmaceuticals AB, Encare AB and Sitbon Bioscience Partner Zenz AB.
TOTAL HOLDINGS (OWN AND RELATED PARTIES): 360,002 shares held privately and through the company Sitbon Bioscience Partner Zenz AB.
Independent in relation to company and company management: Yes
Independent in relation to primary owners: Yes
Mattias Bengtsson
Born 1969
Board member since 2019
Member of the remuneration committee
EDUCATION AND TRAINING:
Master of Science in Chemical Engineering at Chalmers University of Technology in Gothenburg, MBA at University of Gothenburg School of Business
MAIN EXPERIENCE:
Mattias Bengtsson has more than 20 years of experience from the chemical and life science industry. He has held senior positions within AkzoNobel, more specifically in industrial purification of pharmaceuticals, for example as General Manager Kromasil and Fine Chemicals, Global Sales and Marketing Manager, Manufacturing Manager and Product Category Manager. In addition, Mattias has held several positions in process chemistry at AstraZeneca in Södertälje.
OTHER APPOINTMENTS:
Business Unit Manager BioMedical & Research, AddLife AB. Chairman of the board of Bergman Labora AB, LabRobot Products AB and Bioline Scientific AB. Board member of BioNordika (Sweden) AB, MaBeRo Consulting AB, LabVent Control AS, Holm&Halby AS and EuroClone Spa.
TOTAL HOLDINGS (OWN AND RELATED PARTIES): 470,400 shares.
Independent in relation to company and company management: No
Independent in relation to primary owners: Yes
Thomas Eldered
Born 1960
Board member since 2021
Member of the audit committee
EDUCATION AND TRAINING:
Master of Science in Industrial Economics, Linköpings tekniska högskola
MAIN EXPERIENCE:
Thomas Eldered is co-founder of Recipharm AB where he also worked as CEO between 2008–2021. Prior to that, Thomas was Vice President of Recip AB and Factory Manager for Pharmacia. Thomas has also held various assignments as chairman of the board, board member or deputy board member in companies primarily in the life science sector.
OTHER APPOINTMENTS:
Chairman of Flerie Invest AB, Amarna Therapeutics BV, Prokarium Ltd and North X Biologics AB. Board member of Chromafora AB, Bohus Biotech AB, Buzzard Pharmaceuticals AB, Sixera Pharma AB, Kahr Medical Ltd, Flerie Förvaltning AB, Cordinvest AB, Pingvinen Penningplacering AB, Xintela AB (publ), Toleranzia AB (publ), Flerie Participation AB.
TOTAL HOLDINGS (OWN AND RELATED PARTIES): 37,556,209 shares through Flerie Invest AB.
Independent in relation to company and company management: Yes
Independent in relation to primary owners: No
Anders Rabbe
Born 1970
Board member since 2020
Member of the audit committee
EDUCATION AND TRAINING:
Bachelor of Economics in Business Administration from Webster University, Genève.
MAIN EXPERIENCE:
Anders Rabbe has been the CEO of several companies in the biotechnology and financial sector, including Isofol Medical (publ) and WntResearch AB (publ).
OTHER APPOINTMENTS:
CEO of Mindforce Game Lab AB. Board member and partner in Investmentaktieboalget Akkumula, Albonja AB and Epicyt Pharma AB, and deputy board member of Malira AB.
TOTAL HOLDINGS (OWN AND RELATED PARTIES): 144,587 shares through Investmentaktiebolaget Akkumula.
Independent in relation to company and company management: Yes
Independent in relation to primary owners: Yes
Lena Torlegård
Born 1963
Board member since 2014
Chairman of the audit committee
EDUCATION AND TRAINING:
Bachelor of Science in Business Administration from the Stockholm School of Economics
MAIN EXPERIENCE:
Lena Torlegård has over 20 years of experience as a communications consultant for a large number of companies, including companies in the life science industry. Lena works through Lena Torlegård AB as an independent advisor in financial and corporate communication with several customers in the life science sector.
OTHER APPOINTMENTS:
Communications consultant at Lena Torlegård AB.
TOTAL HOLDINGS (OWN AND RELATED PARTIES): 168,704 shares.
Independent in relation to company and company management: Yes
Independent in relation to primary owners: Yes
Alexandra Blomberg Montgomery
Born 1967
Board member since 2024
EDUCATION AND TRAINING:
Bachelor of Science at Stockholms universitet, Diploma from Berghs School of Communication.
MAIN EXPERIENCE:
Alexandra Blomberg Montgomery has extensive experience in advising companies operating in many sectors, through her years as a partner at KREAB where she has also held several senior positions, including in international business development. Furthermore, Alexandra has experience of medical research from a board perspective, for example as a board member of the Ragnar Söderberg Foundation. Alexandra works primarily with investments in both listed and unlisted environments.
OTHER APPOINTMENTS:
CEO and board member of MONTBERG Invest AB. Chairman of the board of Kronprinsessan Lovisas stiftelse för barnasjukvård, stiftelsen Axel Tielmans minnesfond and the Wallenbergska Familjestiftelserna. Board member of Turbotic AB.
TOTAL HOLDINGS (OWN AND RELATED PARTIES): 4,577,381 shares.
Independent in relation to company and company management: Yes
Independent in relation to primary owners: Yes